To order this series click here

    The AHC and the NIH are proud to present this ten-program video/CD-ROM series which features leading experts from the NIH and its participating academic health centers. This latest evidence based medical research is presented in a format which is easily understood and can be readily put into practice. These ten programs are available as a series for $590.00 or can be ordered individually for $125.00 each.
 

1. Diabetes Type II     (NIDDK)
Judith E. Fradkin, MD, Director, Division of Diabetes, Endocrinology, and Metabolic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases
Rena Wing, PhD, Professor of Psychiatry and Human Behavior,  Brown University school of Medicine
Robert Ratner, MD, Vice President for Scientific Affairs, Medstar Research Institute

2. Diabetes Type I     (NIDDK)
Judith E. Fradkin, MD, Director, Division of Diabetes, Endocrinology, and Metabolic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases
Jay S. Skyler, MD, Director, Division of Endocrinology, Diabetes and Metabolism, University of Miami
Martha M. Funnell, MS, RN, CDE, Director for Administration, Michigan Diabetes Research and Training Center

3. Asthma in Children   (NHLBI)
Fernando Martinez, MD, Director, Respiratory Sciences Center, University of Arizona
Robert Strunk, MD, Professor, Department of Pediatrics, Washington University, St. Louis
Gail Shapiro, MD, Board Member, Senior Partner, Northwest Asthma & Allergy Center, ASTHMA, Inc., Seattle, WA
David Evans, PhD, Associate Professor of Clinical Public Health, Department of Pediatrics, Columbia University College of Physicians and Surgeons

4. The Untold Story: Women and Heart Disease   (NHLBI)
Sharonne N. Hayes, MD, FACC, Assistant Professor of Medicine and Cardiology, Mayo Graduate School of Medicine, Director, Mayo Clinic Women's Heart Clinic
Deborah J. Barbour, MD, FACC, FACP, Director, The Heart Program for Women, Mercy Medical Center, Baltimore, MD
Bruce MacLeod, MD, FACEP, Chairman, Department of Emergency Medicine, Mercy Hospital of Pittsburgh

5. Clinical Guidelines on Assessment, Evaluation and Treatment of Overweight and Obese Patients: What Providers Need to Know   (NHLBI)
F. Xavier Pi-Sunyer, MD,  Professor of Medicine, Columbia University College of Physicians and Surgeons, Chief, Endocrinology, Diabetes & Nutrition; Director, Obesity Research Center, St. Luke's-Roosevelt Hospital Center
Louis J. Aronne, MD, Clinical Associate Professor of Medicine, Weill-Cornell Medical College, Adjunct Clinical Associate Professor of Medicine, Columbia University, Director, Comprehensive Weight Control Program
Shiriki Kumanyika, PhD, RD, Professor Epidemiology and Associate Dean for Health Promotion and Disease Prevention, University of Pennsylvania School of Medicine

6. Sleep Apnea: Is Your Patient At Risk?   (NHLBI)
Carl E. Hunt, MD, Director, National Center on Sleep Disorders Research (NHLBI)
Edward Haponik, MD, Prof. of Internal Medicine, Division of Pumonary & Critical Care Medicine, Johns Hopkins Asthma & Allergy Center
Richard Millman, MD, Director, Sleep Disorders Center, Rhode Island Hospital

7. Primary Immunodeficiency Diseases: Diagnosis and Treatment   (NICHD)
Rebecca Buckley, MD, J. Buren Sidbury Professor of Pediatrics, Professor of Immunology, Duke University School of Medicine; Chief, Division of Allergy and Immunology, Duke University Medical Center
Jennifer M. Puck, MD, Chief, Genetics and Molecular Biology Branch, National Human Genome Research Institute
Jerry A. Winkelstein, MD, Department of Pediatric Immunology, The Johns Hopkins University

8. Prostate Cancer: New Opportunities for Diagnosis and Treatment   (NCI)
William M. Linehan, MD, Chief, Urologic Oncology Branch, National Cancer Institute (NCI)
Norman Coleman, MD, Chief, Radiation Oncology Sciences Program, National Cancer Institute
John L. Phillips, MD, Senior Staff, Urologic Oncology Branch, National Cancer Institute
William L. Dahut, MD, Head, Prostate Cancer Clinic, National Cancer Institute

9.  Recombinant Immunotoxin Therapy of Cancer: A Developing Alternative to Chemotherapy for Cancer and Autoimmune Diseases such as HIV     (NCI)
Ira Pastan, MD, Chief, Laboratory of Molecular Biology, National Cancer Institute
Robert J. Kreitman, MD, Chief, Clinical Immunotherapy Section, Laboratory of Molecular Biology, National Cancer Institute
David FitzGerald, PhD, Chief, Biotherapy Section, Laboratory of Molecular Biology,     National Cancer Institute  

10. Breast Cancer: Women at Risk, Prevention Strategies and Current Treatment Options  (NCI)
JoAnne Zujewski, MD, Head, Medical Breast Cancer Section, Medical Oncology Clinical Research Unit, NCI
Sandra Swain, MD, Chief, Cancer Therapeutics Branch, Center for Cancer Research, NCI
Michele Forman, PhD, MS, Senior investigator, Cancer Prevention Studies Branch, Center for Cancer Research, NCI  
 

   These programs will present how diagnosis and treatment of disease can be improved in light of the latest research findings as interpreted by NIH experts. The programs are of interest to primary care physicians, specialists and allied health professionals. This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the National Institutes of Health/Foundation for Advanced Education in the Sciences (NIH/FAES) and the Association of Academic Health Centers.

The NIH/FAES is accredited by the ACCME to provide continuing medical education for physicians.

The NIH/FAES designates this educational activity for a maximum of 1.5 hours in category 1 credit for each program (total of 15 hours for entire series) towards the AMA Physician’s Recognition Award. Each physician should claim only those hours of credit actually spent in the educational activity.

 Click here to order this series
    
  These NIH "Bench to Bedside" programs are a valuable educational resource for major medical institutions, community hospitals, and clinical group practices. They have been produced at the NIH studio facilities in a roundtable format utilizing state of the art television graphics for all presentations. The programs have been designed to engage front line clinical practitioners with "cutting edge" research information that can be easily understood and readily put into practice at the bedside. Each program is approximately sixty minutes in length and is available on both videotape and CD-ROM. Application for CME credit is available on the CenterNet website by clicking on "CME" above and via mail and fax. There is no fee charged for the CME credits.
 

                                            

This series of five recently broadcast programs are now available on videotape. The approximate running time for each program is sixty minutes in length.
The series of five programs is $ 195.00, with individual programs at $125.00 each.
Moderator for all five programs is John Gallin, M.D., Director, Warren Grant Clinical Center at the NIH.

1. MRI in the ER
Robert Balaban, Ph.D., Chief, Laboratory of Cardiac Energetics, National Heart, Lung and Blood Institute (NHLBI): “MRI in the Emergency Department”
Wayne Olan, M.D., Director, Neuroradiology/MRI, Suburban Hospital, Bethesda, MD: “Acute Stroke Imaging”
Andrew Arai, M.D., Investigator, Laboratory of Cardiac Energetics, NHLBI: “Evaluation of Acute Coronary Syndromes by MRI”

2. Diagnosis and Management of Motor Neuron Disease
Marinos Dalakas, M.D., Chief, Neuromuscular Diseases Section, National Institute of Neurological Disorders and Stroke (NINDS): “Clinical Sign, Disease Subsets, and Diagnosis of Amyotrophic Lateral Sclerosis (ALS)”
Jeffrey Rothstein, M.D., Ph.D., Associate Professor of Neurology and Neuroscience, Johns Hopkins University: “Pathogenesis and Therapies for ALS”
Mary Kay Floeter, M.D., Ph.D., Chief, Electromyography Section, NINDS: “Electrodiagnosis in ALS”
Hiroshi Mitsumoto, M.D., Professor Neurology, Columbia University, and Director, Eleanor and  Lou Gehrig Center: “Improving the Quality of Life for Patients with ALS”

3. Tumor Vaccines
Steven Rosenberg, M.D., Chief, Surgery Branch, National Cancer Institute (NCI)  “The Development of Peptide Cancer Vaccines for the Treatment of Patients with Solid Tumors”
Larry Kwak, M.D., Ph.D., Senior Investigator, Department of Experimental Transplantation and Immunology (NCI): “Lymphoma Vaccines”
Jeffrey Schlom, Ph.D., Chief, Laboratory of Tumor Immunology and Biology (NCI): “The Design and Development of Recombinant Vector-Based Vaccines to Elicit High-Intensity Immune  Stimulation”
Jay Berzofsky, M.D., Ph.D., Chief, Molecular Immunogenetics and Vaccines Research Section (NCI): “Mutations and Chromosomal Translocations as Tumor-Unique Vaccine Target for the Immunotherapy of Cancer”

4. Sickle Cell Anemia
Griffin Rodgers, M.D., Chief, Molecular and Clinical Hematology Branch, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK): “Overview of Pathophysiology and Rationale for Specific Treatment Approaches to Sickle Cell Disease”
Mark Gladwin, M.D., Senior Research Fellow, Department of Critical Care Medicine, Clinical Center: “Therapeutic Potential of Nitric Oxide in Patients with Sickle Cell Anemia”
John Tisdale, M.D., Senior Investigator, Molecular and Clinical Hematology Branch (NIDDK): “Toward Gene Replacement Therapy in Sickle Cell Anemia”   

5. Drug Interactions with Complimentary Medicines
Stephen Piscitelli, Pharm.D., Coordinator, Clinical Center Pharmacy Department: “Effect of St. John’s Wort on the Pharmacokinetics of Indinavir”
Aaron Burstein, Pharm.D., Pharmacokineticist, Clinical Pharmacokinetics Research Laboratory, Clinical Center Pharmacy Department: “Overview of Herb-Drug Interactions”
Judith Falloon, M.D., Senior Investigator, Laboratory of  Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID): “Clinical Implications of St. John’s Wort Interactions in HIV Infection”
Kimberly Struble, Pharm.D., Regulatory Review Officer, Center for Drug Evaluation and Research, Food and Drug Administration: “Regulatory Perspective”